Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Leukemia Research|October 5, 2011
Time changes in predictive power of established and recently proposed clinical, cytogenetical and comorbidity scores for Myelodysplastic SyndromesMichael Pfeilstöcker, Heinz Tüchler, Anabel Schönmetzler, et al.
Annals of Hematology|November 28, 2002
Assessment of growth and differentiation processes in myelodysplastic syndromes by PCR analysis of Galpha16 and 5'-lipoxygenaseMichael Pfeilstöcker, Heidrun Karlic, Thomas Nösslinger, et al.
Leukemia & Lymphoma|October 22, 2013
Safety and tolerability of intrathecal liposomal cytarabine as central nervous system prophylaxis in patients with acute lymphoblastic leukemiaAngelika Valentin, Katharina Troppan, Michael Pfeilstöcker, et al.
Wiener Klinische Wochenschrift|August 16, 2019
Recommendations for ibrutinib treatment in patients with atrial fibrillation and/or elevated cardiovascular riskMarkus C Stühlinger, Ansgar Weltermann, Philipp Staber, et al.
Leukemia & Lymphoma|October 6, 2007
Myelodysplastic syndromes, aging, and age: correlations, common mechanisms, and clinical implicationsMichael Pfeilstöcker, Heidrun Karlic, Thomas Nösslinger, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 18, 2008
Impact of age and comorbidity in myelodysplastic syndromesReinhard Stauder, Thomas Nösslinger, Michael Pfeilstöcker, et al.
European Journal of Haematology|August 22, 2003
Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myelomaHannes Kaufmann, Elisabeth Krömer, Thomas Nösslinger, et al.
Annals of Hematology|January 21, 2014
Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trialGeorg Hopfinger, Thomas Nösslinger, Alois Lang, et al.
Wiener Klinische Wochenschrift|November 7, 2008
[Individualized management and therapy of myelodysplastic syndromes]Reinhard Stauder, Friedrich Wimazal, Thomas Nösslinger, et al.
Cancer|June 16, 2004
DNA-methylation analysis identifies the E-cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathiesSonja Seidl, Jutta Ackermann, Hannes Kaufmann, et al.
Pageof 4